Project Grant K08AR088160
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $348K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded $442,595 to The Regents of the University of California, San Francisco on September 19, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846, Project Grant R01AR085315). The recipient will develop machine learning–based prognostic models to predict which children with early-onset atopic dermatitis are more likely to develop persistent disease and comorbid conditions including...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded the University of California, San Diego $559,827 on September 1, 2026, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to investigate the molecular mechanisms regulating inflammatory responses in epidermal keratinocytes. The research will characterize the role of the ZNF750 protein complex and its associated factors (KDM1A/LSD1, SETDB1, TRIM28/KAP1, and HNRNPU) in mediating...
- The National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded Vanderbilt University Medical Center $409,063 on May 15, 2026, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to model hidradenitis suppurativa and link genetic susceptibility loci to disease pathogenesis. The project will use mouse molecular genetics, lentiviral delivery, human keratinocyte bioassays, and RNA sequencing to test whether...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded The Leland Stanford Junior University $204,682 on September 10, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to characterize the roles of RNA-binding protein assemblies in epidermal homeostasis. The recipient will develop and apply two new crosslinking immunoprecipitation-based methods—IRCLIP-RNP and RE-CLIP—to study how RNA-binding proteins organize and...
- Federal Grant Award Summary Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, received a $366,053 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), effective August 1, 2025, through June 30, 2027. This award supports fundamental biomedical research investigating the role of non-classical Type I interferons in...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded Incuta Therapeutics LLC $321,630 on September 1, 2026, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to develop an injectable baricitinib hydrogel for treating hidradenitis suppurativa. The project advances a localized therapeutic delivery system designed to overcome the systemic safety risks associated with JAK inhibitors used in hidradenitis suppurativa treatment. Incuta...
- The National Institute of Allergy and Infectious Diseases awarded The Regents of the University of California, San Francisco $222,085 on October 24, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct research on skin microbiota-immune interactions that drive early life commensal tolerance. The research investigates how cutaneous immune cells maintain tolerance to skin commensal microbes while defending against pathogens, with focus on the role of CD301B+...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded $1.9M in Project Grant funding (CFDA 93.846: Arthritis, Musculoskeletal and Skin Diseases Research) to the University of California, San Francisco on September 15, 2025, for a three-year research initiative through August 31, 2028. This award supports research into the dysregulation of epidermal innate immune signaling as a driver of psoriatic arthritis (PsA). The project...
- The National Institute of Allergy and Infectious Diseases awarded The Johns Hopkins University $271,574 on November 3, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct research on gamma secretase dysregulation in acquired hidradenitis suppurativa. The project, titled "Dysregulation of Gamma Secretase in Common Acquired Hidradenitis Suppurativa" (F30AI191436), investigates the molecular mechanisms underlying hidradenitis suppurativa, a chronic...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded New York University $148,062 on September 30, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The funded research investigates the mechanism by which epithelial stem and progenitor cells encode inflammatory memory in psoriasis and other remitting-relapsing inflammatory disorders. The study tests whether homeostatic and inflammatory transcription factors dynamically...